Study into medication known as ‘King Kong’ of weight loss drugs throws fresh light on effects of longer-term use
People who use the drug Mounjaro are able to sustain weight loss for three years, data from a trial suggests.
Mounjaro, nicknamed the “King Kong” of weight loss drugs, contains tirzepatide and is self-administered in once-a-week injections.
More Stories
Weight-loss jabs may be good for mental health, research shows
Australia has been hesitant – but could robots soon be delivering your pizza?
AI firms warned to calculate threat of super intelligence or risk it escaping human control